“Bimekizumab impact on draining tunnels: A dynamic assessment in patients with moderate to severe HS using pooled Week 48 results from BE HEARD I&II” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s475. doi:10.25251/skin.8.supp.475.